Yuval Cohen, Chief Executive Officer at Corbus Pharmaceuticals Holdings, Inc. (CRBP), bought 995 shares at $6.99 ($7K) on 2019-05-13, disclosed to the SEC on 2019-05-14.
Seasonal purchase ($7k) by Chief Executive Officer — this insider has traded CRBP in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| CRBP | SELL | 2025-10-27 | $942K | — | Filing → |
| CRBP | SELL | 2025-02-18 | $125K | — | Filing → |
| CRBP | SELL | 2024-06-18 | $5.9M | — | Filing → |